サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Global Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Region, Industry Analysis and Forecast, 2020 - 2026

硬化療法の世界市場 - 業界分析と予測(2020年〜2026年)

レポート概要

世界の硬化療法の市場規模は2026年までに12億ドルに達すると予想され、予測期間中にCAGR 7.9%の市場成長率で上昇すると見込まれています。硬化療法は、静脈瘤の治療に使用される低侵襲性治療です。この処置では、硬化剤の溶液を患部の静脈に直接注射し、その結果、静脈が収縮し、最終的には消失します。硬化療法は、血管やリンパ系の奇形の治療に役立つ医療処置です。

硬化療法は通常、成人のクモ状静脈瘤、痔核、および小さな静脈瘤の治療に使用されます。硬化療法では、非常に細い注射針を使用して溶液を注射し、脚の小さな静脈瘤を治療し、クモ状静脈瘤の見た目を改善し、灼熱感、痛み、腫れ、けいれんなどの関連症状を取り除きます。皮膚科医は、より大きな静脈瘤と美容毛細血管拡張症の治療に使用できる新しい安全で非侵襲的な技術の進歩に重要な役割を果たしており、医学的に重要になっています。硬化ソリューション、血管内RFおよびレーザー手順で大きな進歩が見られ、ヘルスケア業界に革命をもたらしました。

現在のシナリオでは、より評判のよい病院は、硬化療法治療を含む低侵襲性の外科的処置を選択することを好みます。静脈瘤の治療に使用される硬化剤は、洗剤、高浸透圧/浸透圧剤、化学刺激物質に分類されます。テトラデシル硫酸ナトリウム(ソトラデコール)とポリドカノール(アスクレラ)、モルヒ酸ナトリウム(スクレロメート)、オレイン酸エタノールアミン(エタモリン)などの薬剤は全て、静脈の損傷の治療と軽減に使用されるFDA承認の硬化剤です。血管外科学会によると、先進国の毛細血管拡張症と静脈瘤については、女性の33.0%以上、男性の約17.0%が医師の診察を受けており、アメリカだけで35.0%もの人が罹患しています。

薬剤に基づいて、市場は洗剤、浸透剤、化学刺激剤に分割されます。タイプに基づいて、市場は液体硬化療法、超音波硬化療法、フォーム硬化療法に分割されます。地域別では、北アメリカ、ヨーロッパ、アジア太平洋地域、ラテンアメリカ、中東およびアフリカに分割されます。

本市場調査レポートは、市場の主要な利害関係者の分析をカバーしています。本レポートが調査する企業には、Boston Scientific Corporation社、Perrigo Company PLC (Omega Pharmaceuticals)社、Cook Medical, Inc. (Cook Group)社、Chemische Fabrik Kreussler & Co. GmbH社、LGM Pharma, LLC社、Troikaa Pharmaceuticals Limited社、Tianyu Chang’an Group社、Endo-Flex GmbH (Meditek Systems)社、Merz Pharma GmbH & Co. KGaA社、およびMTW-Endoskopie W. Haag KG社が含まれます。

■ 調査範囲

  • 薬剤別
    ➣ 洗剤
    ➣ 化学刺激剤
    ➣ 浸透剤
  • タイプ別
    ➣ 液体
    ➣ 超音波
    ➣ フォーム
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
      ◇ メキシコ
      ◇ その他の北アメリカ
    ➣ ヨーロッパ
      ◇ ドイツ
      ◇ イギリス
      ◇ フランス
      ◇ ロシア
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ 日本
      ◇ インド
      ◇ 韓国
      ◇ シンガポール
      ◇ マレーシア
      ◇ その他のアジア太平洋
    ➣ LAMEA
      ◇ ブラジル
      ◇ アルゼンチン
      ◇ UAE
      ◇ サウジアラビア
      ◇ 南アフリカ
      ◇ ナイジェリア
      ◇ その他のLAMEA
  • 調査企業
      ◇ Boston Scientific Corporation
      ◇ Perrigo Company PLC (Omega Pharmaceuticals)
      ◇ Cook Medical, Inc. (Cook Group)
      ◇ Chemische Fabrik Kreussler & Co. GmbH
      ◇ LGM Pharma, LLC
      ◇ Troikaa Pharmaceuticals Limited
      ◇ Tianyu Chang’an Group
      ◇ Endo-Flex GmbH (Meditek Systems)
      ◇ Merz Pharma GmbH & Co. KGaA
      ◇ MTW-Endoskopie W. Haag KG

レポート詳細

目次

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Sclerotherapy Market, by Agent
1.4.2 Global Sclerotherapy Market, by Type
1.4.3 Global Sclerotherapy Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Sclerotherapy Market by Agent
3.1 Global Detergents Market by Region
3.2 Global Osmotic Agents Market by Region
3.3 Global Chemical Irritants Market by Region

Chapter 4. Global Sclerotherapy Market by Type
4.1 Global Liquid Sclerotherapy Market by Region
4.2 Global Ultrasound Sclerotherapy Market by Region
4.3 Global Other Type Market by Region

Chapter 5. Global Sclerotherapy Market by Region
5.1 North America Sclerotherapy Market
5.1.1 North America Sclerotherapy Market by Agent
5.1.1.1 North America Detergents Market by Country
5.1.1.2 North America Osmotic Agents Market by Country
5.1.1.3 North America Chemical Irritants Market by Country
5.1.2 North America Sclerotherapy Market by Type
5.1.2.1 North America Liquid Sclerotherapy Market by Country
5.1.2.2 North America Ultrasound Sclerotherapy Market by Country
5.1.2.3 North America Other Type Market by Country
5.1.3 North America Sclerotherapy Market by Country
5.1.3.1 US Sclerotherapy Market
5.1.3.1.1 US Sclerotherapy Market by Agent
5.1.3.1.2 US Sclerotherapy Market by Type
5.1.3.2 Canada Sclerotherapy Market
5.1.3.2.1 Canada Sclerotherapy Market by Agent
5.1.3.2.2 Canada Sclerotherapy Market by Type
5.1.3.3 Mexico Sclerotherapy Market
5.1.3.3.1 Mexico Sclerotherapy Market by Agent
5.1.3.3.2 Mexico Sclerotherapy Market by Type
5.1.3.4 Rest of North America Sclerotherapy Market
5.1.3.4.1 Rest of North America Sclerotherapy Market by Agent
5.1.3.4.2 Rest of North America Sclerotherapy Market by Type
5.2 Europe Sclerotherapy Market
5.2.1 Europe Sclerotherapy Market by Agent
5.2.1.1 Europe Detergents Market by Country
5.2.1.2 Europe Osmotic Agents Market by Country
5.2.1.3 Europe Chemical Irritants Market by Country
5.2.2 Europe Sclerotherapy Market by Type
5.2.2.1 Europe Liquid Sclerotherapy Market by Country
5.2.2.2 Europe Ultrasound Sclerotherapy Market by Country
5.2.2.3 Europe Other Type Market by Country
5.2.3 Europe Sclerotherapy Market by Country
5.2.3.1 Germany Sclerotherapy Market
5.2.3.1.1 Germany Sclerotherapy Market by Agent
5.2.3.1.2 Germany Sclerotherapy Market by Type
5.2.3.2 UK Sclerotherapy Market
5.2.3.2.1 UK Sclerotherapy Market by Agent
5.2.3.2.2 UK Sclerotherapy Market by Type
5.2.3.3 France Sclerotherapy Market
5.2.3.3.1 France Sclerotherapy Market by Agent
5.2.3.3.2 France Sclerotherapy Market by Type
5.2.3.4 Russia Sclerotherapy Market
5.2.3.4.1 Russia Sclerotherapy Market by Agent
5.2.3.4.2 Russia Sclerotherapy Market by Type
5.2.3.5 Spain Sclerotherapy Market
5.2.3.5.1 Spain Sclerotherapy Market by Agent
5.2.3.5.2 Spain Sclerotherapy Market by Type
5.2.3.6 Italy Sclerotherapy Market
5.2.3.6.1 Italy Sclerotherapy Market by Agent
5.2.3.6.2 Italy Sclerotherapy Market by Type
5.2.3.7 Rest of Europe Sclerotherapy Market
5.2.3.7.1 Rest of Europe Sclerotherapy Market by Agent
5.2.3.7.2 Rest of Europe Sclerotherapy Market by Type
5.3 Asia Pacific Sclerotherapy Market
5.3.1 Asia Pacific Sclerotherapy Market by Agent
5.3.1.1 Asia Pacific Detergents Market by Country
5.3.1.2 Asia Pacific Osmotic Agents Market by Country
5.3.1.3 Asia Pacific Chemical Irritants Market by Country
5.3.2 Asia Pacific Sclerotherapy Market by Type
5.3.2.1 Asia Pacific Liquid Sclerotherapy Market by Country
5.3.2.2 Asia Pacific Ultrasound Sclerotherapy Market by Country
5.3.2.3 Asia Pacific Other Type Market by Country
5.3.3 Asia Pacific Sclerotherapy Market by Country
5.3.3.1 China Sclerotherapy Market
5.3.3.1.1 China Sclerotherapy Market by Agent
5.3.3.1.2 China Sclerotherapy Market by Type
5.3.3.2 Japan Sclerotherapy Market
5.3.3.2.1 Japan Sclerotherapy Market by Agent
5.3.3.2.2 Japan Sclerotherapy Market by Type
5.3.3.3 India Sclerotherapy Market
5.3.3.3.1 India Sclerotherapy Market by Agent
5.3.3.3.2 India Sclerotherapy Market by Type
5.3.3.4 South Korea Sclerotherapy Market
5.3.3.4.1 South Korea Sclerotherapy Market by Agent
5.3.3.4.2 South Korea Sclerotherapy Market by Type
5.3.3.5 Singapore Sclerotherapy Market
5.3.3.5.1 Singapore Sclerotherapy Market by Agent
5.3.3.5.2 Singapore Sclerotherapy Market by Type
5.3.3.6 Malaysia Sclerotherapy Market
5.3.3.6.1 Malaysia Sclerotherapy Market by Agent
5.3.3.6.2 Malaysia Sclerotherapy Market by Type
5.3.3.7 Rest of Asia Pacific Sclerotherapy Market
5.3.3.7.1 Rest of Asia Pacific Sclerotherapy Market by Agent
5.3.3.7.2 Rest of Asia Pacific Sclerotherapy Market by Type
5.4 LAMEA Sclerotherapy Market
5.4.1 LAMEA Sclerotherapy Market by Agent
5.4.1.1 LAMEA Detergents Market by Country
5.4.1.2 LAMEA Osmotic Agents Market by Country
5.4.1.3 LAMEA Chemical Irritants Market by Country
5.4.2 LAMEA Sclerotherapy Market by Type
5.4.2.1 LAMEA Liquid Sclerotherapy Market by Country
5.4.2.2 LAMEA Ultrasound Sclerotherapy Market by Country
5.4.2.3 LAMEA Other Type Market by Country
5.4.3 LAMEA Sclerotherapy Market by Country
5.4.3.1 Brazil Sclerotherapy Market
5.4.3.1.1 Brazil Sclerotherapy Market by Agent
5.4.3.1.2 Brazil Sclerotherapy Market by Type
5.4.3.2 Argentina Sclerotherapy Market
5.4.3.2.1 Argentina Sclerotherapy Market by Agent
5.4.3.2.2 Argentina Sclerotherapy Market by Type
5.4.3.3 UAE Sclerotherapy Market
5.4.3.3.1 UAE Sclerotherapy Market by Agent
5.4.3.3.2 UAE Sclerotherapy Market by Type
5.4.3.4 Saudi Arabia Sclerotherapy Market
5.4.3.4.1 Saudi Arabia Sclerotherapy Market by Agent
5.4.3.4.2 Saudi Arabia Sclerotherapy Market by Type
5.4.3.5 South Africa Sclerotherapy Market
5.4.3.5.1 South Africa Sclerotherapy Market by Agent
5.4.3.5.2 South Africa Sclerotherapy Market by Type
5.4.3.6 Nigeria Sclerotherapy Market
5.4.3.6.1 Nigeria Sclerotherapy Market by Agent
5.4.3.6.2 Nigeria Sclerotherapy Market by Type
5.4.3.7 Rest of LAMEA Sclerotherapy Market
5.4.3.7.1 Rest of LAMEA Sclerotherapy Market by Agent
5.4.3.7.2 Rest of LAMEA Sclerotherapy Market by Type

Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview

LIST OF TABLES
TABLE 1 GLOBAL SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 2 GLOBAL SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 3 GLOBAL SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 4 GLOBAL SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 5 GLOBAL DETERGENTS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 6 GLOBAL DETERGENTS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 7 GLOBAL OSMOTIC AGENTS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 8 GLOBAL OSMOTIC AGENTS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 9 GLOBAL CHEMICAL IRRITANTS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 10 GLOBAL CHEMICAL IRRITANTS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 11 GLOBAL SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 12 GLOBAL SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 13 GLOBAL LIQUID SCLEROTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 14 GLOBAL LIQUID SCLEROTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 15 GLOBAL ULTRASOUND SCLEROTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 16 GLOBAL ULTRASOUND SCLEROTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 17 GLOBAL OTHER TYPE MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 18 GLOBAL OTHER TYPE MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 19 GLOBAL SCLEROTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 20 GLOBAL SCLEROTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 21 NORTH AMERICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 22 NORTH AMERICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 NORTH AMERICA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 NORTH AMERICA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 NORTH AMERICA OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 38 NORTH AMERICA OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 39 NORTH AMERICA SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 40 NORTH AMERICA SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 41 US SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 42 US SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 43 US SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 44 US SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 45 US SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 46 US SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 47 CANADA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 48 CANADA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 49 CANADA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 50 CANADA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 51 CANADA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 52 CANADA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 53 MEXICO SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 54 MEXICO SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 55 MEXICO SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 56 MEXICO SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 57 MEXICO SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 58 MEXICO SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 59 REST OF NORTH AMERICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 60 REST OF NORTH AMERICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 61 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 62 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 63 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 64 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 65 EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 66 EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 67 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 68 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 69 EUROPE DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 70 EUROPE DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 71 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 72 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 73 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 74 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 75 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 76 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 77 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 78 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 79 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 80 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 81 EUROPE OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 82 EUROPE OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 83 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 84 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 85 GERMANY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 86 GERMANY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 87 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 88 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 89 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 90 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 91 UK SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 92 UK SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 93 UK SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 94 UK SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 95 UK SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 96 UK SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 97 FRANCE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 98 FRANCE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 99 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 100 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 101 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 102 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 103 RUSSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 104 RUSSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 105 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 106 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 107 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 108 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 109 SPAIN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 110 SPAIN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 111 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 112 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 113 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 114 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 115 ITALY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 116 ITALY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 117 ITALY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 118 ITALY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 119 ITALY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 120 ITALY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 121 REST OF EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 122 REST OF EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 123 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 124 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 125 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 126 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 127 ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 128 ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 129 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 130 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 131 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 132 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 133 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 134 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 135 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 136 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 137 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 138 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 139 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 140 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 141 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 142 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 143 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 144 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 145 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 146 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 147 CHINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 148 CHINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 149 CHINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 150 CHINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 151 CHINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 152 CHINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 153 JAPAN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 154 JAPAN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 155 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 156 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 157 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 158 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 159 INDIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 160 INDIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 161 INDIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 162 INDIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 163 INDIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 164 INDIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 165 SOUTH KOREA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 166 SOUTH KOREA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 167 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 168 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 169 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 170 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 171 SINGAPORE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 172 SINGAPORE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 173 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 174 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 175 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 176 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 177 MALAYSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 178 MALAYSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 179 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 180 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 181 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 182 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 183 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 184 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 185 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 186 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 187 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 188 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 189 LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 190 LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 191 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 192 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 193 LAMEA DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 194 LAMEA DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 195 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 196 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 197 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 198 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 199 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 200 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 201 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 202 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 203 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 204 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 205 LAMEA OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 206 LAMEA OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 207 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 208 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 209 BRAZIL SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 210 BRAZIL SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 211 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 212 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 213 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 214 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 215 ARGENTINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 216 ARGENTINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 217 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 218 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 219 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 220 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 221 UAE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 222 UAE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 223 UAE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 224 UAE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 225 UAE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 226 UAE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 227 SAUDI ARABIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 228 SAUDI ARABIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 229 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 230 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 231 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 232 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 233 SOUTH AFRICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 234 SOUTH AFRICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 235 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 236 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 237 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 238 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 239 NIGERIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 240 NIGERIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 241 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 242 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 243 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 244 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 245 REST OF LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 246 REST OF LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 247 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 248 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 249 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 250 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 251 KEY INFORMATION - BOSTON SCIENTIFIC CORPORATION
TABLE 252 KEY INFORMATION - PERRIGO COMPANY PLC
TABLE 253 KEY INFORMATION - COOK MEDICAL, INC.
TABLE 254 KEY INFORMATION - CHEMISCHE FABRIK KREUSSLER & CO. GMBH
TABLE 255 KEY INFORMATION - LGM PHARMA, LLC
TABLE 256 KEY INFORMATION - TROIKAA PHARMACEUTICALS LIMITED
TABLE 257 KEY INFORMATION - TIANYU CHANG’AN GROUP
TABLE 258 KEY INFORMATION -ENDO-FLEX GMBH
TABLE 259 KEY INFORMATION - MERZ PHARMA GMBH & CO. KGAA
TABLE 260 KEY INFORMATION - MTW-ENDOSKOPIE W. HAAG KG

LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH

発刊日

2020/10/31

体裁

PDF / 132ページ

販売価格

3,600USD

発行

KBV Research

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品原料・製剤 / 創薬一般 / 疾病別治療・領域別治療 / 医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE